Gene · 2280
Papers1,820
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,820
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Hif1α as a Potential Participant in Autoimmune Uveitis Pathogenesis Using Single-Cell Transcriptome Analysis. | Invest Ophthalmol Vis Sci | 2023 | 37227746 | PubTator, text mining | PubMed |
| A publication-wide association study (PWAS), historical language models to prioritise novel therapeutic drug targets. | Sci Rep | 2023 | 37225853 | PubTator, text mining | PubMed |
| Mechanistic/mammalian target of rapamycin complex 1 (mTORC1) signaling is involved in phagocytosis activation during THP-1 cell differentiation. | J Vet Med Sci | 2023 | 37225457 | PubTator, text mining | PubMed |
| Unbiased evaluation of rapamycin's specificity as an mTOR inhibitor. | Aging Cell | 2023 | 37222020 | PubTator, text mining | PubMed |
| RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cells. | Gene Ther | 2023 | 37173386 | PubTator, text mining | PubMed |
| Nanoscale Phosphoinositide Distribution on Cell Membranes of Mouse Cerebellar Neurons. | J Neurosci | 2023 | 37160366 | PubTator, text mining | PubMed |
Dissecting order amidst chaos of programmed cell deaths: construction of a diagnostic model for KIRC using transcriptomic information in blood-derived exosomes and single-cell multi-omics data in tumor microenvironment. | Front Immunol | 2023 | 37153569 | PubTator, text mining | PubMed |
| Aberrant serum and tissue levels of Beclin1 and mechanistic target of rapamycin (mTOR) proteins in epithelial ovarian cancer. | Medicine (Baltimore) | 2023 | 37115089 | PubTator, text mining | PubMed |
| Oscillation of Autophagy Induction under Cellular Stress and What Lies behind It, a Systems Biology Study. | Int J Mol Sci | 2023 | 37108830 | PubTator, text mining | PubMed |
| Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management. | Int J Mol Sci | 2023 | 37108214 | PubTator, text mining | PubMed |
| WaterKit: Thermodynamic Profiling of Protein Hydration Sites. | J Chem Theory Comput | 2023 | 37094087 | PubTator, text mining | PubMed |
| How can we modulate aging through nutrition and physical exercise? An epigenetic approach. | Aging (Albany NY) | 2023 | 37086262 | PubTator, text mining | PubMed |
| Long noncoding RNA SNHG15: A promising target in human cancers. | Front Oncol | 2023 | 37056344 | PubTator, text mining | PubMed |
| Skeletal muscle atrophy, regeneration, and dysfunction in heart failure: Impact of exercise training. | J Sport Health Sci | 2023 | 37040849 | PubTator, text mining | PubMed |
| A kinesin-based approach for inducing chromosome-specific mis-segregation in human cells. | EMBO J | 2023 | 37038978 | PubTator, text mining | PubMed |
| Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer. | Front Oncol | 2023 | 37025585 | PubTator, text mining | PubMed |
| Precision sirolimus dosing in children: The potential for model-informed dosing and novel drug monitoring. | Front Pharmacol | 2023 | 37021042 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| WSSV exploits AMPK to activate mTORC2 signaling for proliferation by enhancing aerobic glycolysis. | Commun Biol | 2023 | 37012372 | PubTator, text mining | PubMed |
| Large animal models for cardiac remuscularization studies: A methodological review. | Front Cardiovasc Med | 2023 | 37008331 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2280/papers?page=9